Document Detail

Postprandial lipid handling.
MedLine Citation:
PMID:  11224651     Owner:  NLM     Status:  MEDLINE    
The etiological importance of postprandial lipid metabolism in the development of coronary artery disease is now well established. Since then, the work of Patsch and others has helped to establish the etiological importance of postprandial lipid metabolism in the development of coronary artery disease. Dietary and pharmacological interventions have been shown to produce dramatic improvement in postprandial lipid handling in high risk groups and have potential to prevent coronary artery disease through these effects. Research effort continues to focus on the complex mechanisms which underlie defects in postprandial lipid handling, with a view to understanding how lifestyle variables such as diet can be modified to prevent coronary artery disease.
B A Griffin; B A Fielding
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current opinion in clinical nutrition and metabolic care     Volume:  4     ISSN:  1363-1950     ISO Abbreviation:  Curr Opin Clin Nutr Metab Care     Publication Date:  2001 Mar 
Date Detail:
Created Date:  2001-03-06     Completed Date:  2001-07-26     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9804399     Medline TA:  Curr Opin Clin Nutr Metab Care     Country:  England    
Other Details:
Languages:  eng     Pagination:  93-8     Citation Subset:  IM    
Centre for Nutrition and Food Safety, School of Biomedical and Life Sciences, University of Surrey, Guildford, Surrey, GU2 7XH, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antilipemic Agents / pharmacology
Apolipoproteins E / genetics
Cholesterol, VLDL / physiology
Chylomicrons / biosynthesis,  metabolism
Coronary Disease / etiology,  prevention & control*
Dietary Fats / pharmacokinetics,  pharmacology
Endothelium, Vascular / physiology
Intestinal Absorption / physiology
Life Style
Lipid Metabolism*
Lipids / blood
Postprandial Period*
Reg. No./Substance:
0/Antilipemic Agents; 0/Apolipoproteins E; 0/Cholesterol, VLDL; 0/Chylomicrons; 0/Dietary Fats; 0/Lipids

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Aortic valve replacement: current clinical practice and opportunities for quality improvement.
Next Document:  Hyperlipidemia and inhibitors of HIV protease.